Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/GNT1140715]
Researchers:
Prof Geoffrey Lindeman
(Principal investigator)
,
A/Pr Prudence Francis
,
Prof Christian Singer
,
Prof Christobel Saunders
,
Prof Gregory Mann
View all 7 related researchers
Brief description Women with a faulty BRCA1 gene are at high lifetime risk for breast cancer. Identifying a safe and effective prevention therapy is therefore a ‘holy grail’. We have discovered that denosumab, used to treat osteoporosis or breast cancer spread to bone, could be ‘repurposed’ as a prevention drug. BRCA-P is an international randomised controlled study that will determine if denosumab prevents breast cancer. Associated translational research will facilitate swift transfer to the clinic.
Funding Amount $2,589,049.00
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : GNT1140715
- PURL : https://purl.org/au-research/grants/nhmrc/GNT1140715